Officer and Director Stock Option Grant

Vijay Satyanand Pande, a director at BioAge Labs, Inc., was granted 22,000 stock options on June 10, 2026. The options have an exercise price of $15.48 per share and an expiration date of June 9, 2036. The entire award will vest on the earlier of the next annual meeting or the one-year anniversary of the grant date, contingent upon continued service. The options are for the right to buy BioAge Labs Common Stock.